Skip to main content

ADHD Archives

White House assembles top minds in neuroscience and learning for workshop

Feb. 3, 2015—Vanderbilt's Laurie Cutting was one of a select group of experts in neuroscience, cognitive science, developmental psychology and other disciplines invited to take part in a White House Office of Science and Technology Policy workshop.

Read more


‘Darting’ mice may hold clues to ADHD, autism and bipolar disorder

Oct. 23, 2014—The transgenic mouse, into which was inserted a rare human genetic variation in the dopamine transporter, could lead to improvements in the diagnosis and treatment of these all-too-common brain disorders.

Read more


U.S. Senate hearing explores ADHD treatment concerns

Feb. 27, 2014—William Cooper, M.D., MPH, Cornelius Vanderbilt Professor of Pediatrics and Health Policy, testified Tuesday before the U.S. Senate Health, Education, Labor and Pensions (HELP) committee regarding psychotropic medications and treatments for Attention Deficit Hyperactivity Disorder (ADHD).

Read more


Neurotransmitter’s role in bone balance

Nov. 7, 2013—Removal of the neurotransmitter norepinephrine from the space outside cells plays an important role in the regulation of bone remodeling.

Read more


Transporter linked to autism risk

Sep. 19, 2013—Vanderbilt University investigators for the first time have linked a non-inherited, de novo mutation in the dopamine transporter to autism spectrum disorder (ASD).

Read more


Antipsychotic drug use in children for mood/behavior disorders increases type 2 diabetes risk

Aug. 22, 2013—Prescribing “atypical” antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows.

Read more


New clue to ADHD

May. 15, 2012—A rare genetic change adds support to the idea that altered dopamine signaling is a key risk factor for ADHD.

Read more


Minds wide open: Neuroscience at Vanderbilt

Apr. 6, 2012—Vanderbilt University has emerged as one of the nation’s leading academic centers in neuroscience.

Read more


Study finds no heart risk with ADHD drugs

Nov. 3, 2011—Attention deficit hyperactivity disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005.

Read more


Vanderbilt study finds no heart risk in ADHD medications

Nov. 2, 2011—Attention Deficit Hyperactivity Disorder (ADHD) medications do not increase the risk for heart disease or heart attack in children and young adults, according to a Vanderbilt study of 1.2 million patients taking drugs including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005.

Read more


New insight into impulse control

Aug. 30, 2011—How the brain is wired to control impulsive behavior differs significantly from what psychologists have thought, new research finds.

Read more


Upcoming Events

MORE EVENTS »